Cutera | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Cutera

An SI Board Since January 2024

Posts	SubjectMarks	Bans	Symbol
21	1	0	CUTR

Emcee: Harshu Vyas	Type: Moderated

Introduction Market Data Compact

Cutera has proved that it is a stock that can squeeze. But the squeeze is only a catalyst. What's the real value of this company? Discuss.

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
21	CUTR - up over 75% in the last month. I sold on their last earnings and am waiti	Harshu Vyas	-	5/3/2024
20	I sold at the open.	Harshu Vyas	-	3/22/2024
19	I was wrong about Cutera. I've dropped my PT from $10 to $5 and am looking t	Harshu Vyas	-	3/22/2024
18	My understanding of convertible notes is slightly off. Cutera need to get thei	Harshu Vyas	-	3/21/2024
17	Couple things - Cutera Introduces Cutera Academy and New Business Model for Av	Harshu Vyas	-	3/19/2024
16	Volume has dried up - imagine it will pick up on the 20th and the days following	Harshu Vyas	-	3/18/2024
15	When this is all over, I swear to never buy another company like Cutera again. I	Harshu Vyas	-	3/13/2024
14	AviClear now available in the Middle East! I noticed the Cutera sales force + Ta	Harshu Vyas	-	3/12/2024
13	Based on the Company's current plans, the Company believes that its current	Harshu Vyas	-	3/6/2024
12	Before and After Acne Laser Results You Have to See to Believe (newbeauty.com)	Harshu Vyas	-	3/5/2024
11	Ah, an answer. Finally. Cutera to Announce Fourth Quarter and Full-Year 2023 R	Harshu Vyas	-	3/1/2024
10	Jeez, this stock is like a toxic girlfriend. No stability and a constant headach	Harshu Vyas	-	2/29/2024
9	Welp. It's broken support and we're into the $2.2s... what does the mark	Harshu Vyas	-	2/28/2024
8	My concern now is the silence from management and the IR team. No conference cal	Harshu Vyas	-	2/28/2024
7	Cutera maintains its support at the $2.39 (ish) level. Problem, as I see it, is	Harshu Vyas	-	2/27/2024
6	Ok, so it seems the way CUTR's stock trades is simple. Big % gains on up day	Harshu Vyas	-	2/6/2024
5	Taylor Harris was CFO of Zeltiq before it was acquired and failed to file timely	Harshu Vyas	-	2/1/2024
4	For those interested, from what I've gathered UK derms are charging about &#	Harshu Vyas	-	1/31/2024
3	Two things that I haven't really discussed - 1. In the event of a liquidati	Harshu Vyas	-	1/31/2024
2	Look closer. We're moving... even though the company's keeping these sm	Harshu Vyas	-	1/30/2024
1	Cutera down more than 10% as the momentum shifts back towards the sellers. That&	Harshu Vyas	-	1/12/2024

Go to reply# or date (mm/dd/yy):